Global Live Cell Imaging Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Live Cell Imaging Market is presumed to reach the market size of nearly USD 7.35 Billion by 2032 from USD 2.94 Billion in 2023 with a CAGR of 10.73% under the study period 2024-2032.

Live-cell imaging is a microscopy method that enables rapid and long-term observation of cells in vivo. Microscopy techniques suitable for live-cell imaging include traditional contrast techniques, such as differential interference contrast or phase contrast, and fluorescence-based approaches. Scientists use it to understand biological activities better using cellular dynamics. It also aids in studying dynamic complex molecule construction and interaction, viral particle activity, and cellular responses to environmental signals. Live-cell imaging can monitor molecules within animals because of recent improvements in technology such as algorithms and data processing. The live-cell imaging technology is gaining popularity in the medical field.

MARKET DYNAMICS

Over the projected period, the live cell imaging market is predicted to grow in importance. The growing prevalence of infectious and chronic illnesses increases the necessity for effective research and development to understand better cell processes to tackle medical disorders. The increasing interest among researchers and scientists in cell-based research is driving the adoption of innovative imaging technologies, boosting demand for the live-cell imaging market. In addition, one of the critical causes driving the rise in demand for this technology is the growing worry about cancer, so the government is aggressively funding cell-based research. For uncovering new medicines, pharmaceutical companies are increasingly using live cell imaging in their research and development, thereby propelling market growth. However, the scarcity of qualified professionals and the high cost of high-content screening devices may stifle market expansion throughout the forecast timeline.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Live Cell Imaging. The growth and trends of Live Cell Imaging industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Live Cell Imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Instruments (Microscopes Standalone Systems Cell Analysers Accessories)
Consumables (Reagents Assay Kits Media Other Consumables)
Software
Services

By Application

Cell Biology
Stem Cells
Developmental Biology
Drug Discovery

By Technology

Time-Lapse Microscopy
Fluorescence Resonance Energy Transfer (FRET)
Fluorescence Recovery After Photobleaching (FRAP)
High Content Screening (HCS)
Other Technologies

By End User

Pharmaceutical & Biotechnology Companies
Academic and Research Institutes
Contract Research Organisations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Live Cell Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Live Cell Imaging market include Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies Inc. (US), Thermo Fisher Scientific Inc. (US), Etaluma Inc. (US), Cytosmart Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson And Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11217433

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. LIVE CELL IMAGING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Technology
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY PRODUCT & SERVICE

5.1. Overview By Product & Service
5.2. Historical and Forecast Data Analysis By Product & Service
5.3. Instruments (Microscopes Standalone Systems Cell Analysers Accessories) Historic and Forecast Sales By Regions
5.4. Consumables (Reagents Assay Kits Media Other Consumables) Historic and Forecast Sales By Regions
5.5. Software Historic and Forecast Sales By Regions
5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Cell Biology Historic and Forecast Sales By Regions
6.4. Stem Cells Historic and Forecast Sales By Regions
6.5. Developmental Biology Historic and Forecast Sales By Regions
6.6. Drug Discovery Historic and Forecast Sales By Regions

7. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY TECHNOLOGY

7.1. Overview By Technology
7.2. Historical and Forecast Data Analysis By Technology
7.3. Time-Lapse Microscopy Historic and Forecast Sales By Regions
7.4. Fluorescence Resonance Energy Transfer (FRET) Historic and Forecast Sales By Regions
7.5. Fluorescence Recovery After Photobleaching (FRAP) Historic and Forecast Sales By Regions
7.6. High Content Screening (HCS) Historic and Forecast Sales By Regions
7.7. Other Technologies Historic and Forecast Sales By Regions

8. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY END USER

8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
8.4. Academic and Research Institutes Historic and Forecast Sales By Regions
8.5. Contract Research Organisations Historic and Forecast Sales By Regions

9. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE LIVE CELL IMAGING COMPANIES

10.1. Live Cell Imaging Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF LIVE CELL IMAGING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Danaher (US)
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. ZEISS Group (Germany)
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Nikon Corporation (Japan)
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Olympus Corporation (Japan)
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. PerkinElmer Inc. (US)
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Sartorius AG (Germany)
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Agilent Technologies Inc. (US)
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Thermo Fisher Scientific Inc. (US)
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Etaluma Inc. (US)
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Cytosmart Technologies (Netherlands)
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. NanoEnTek Inc. (South Korea)
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. GE Healthcare (US)
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Bruker Corporation (US)
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Becton
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. Dickinson And Company (BD) (US)
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments
11.18. Merck KGaA (Germany)
- 11.18.1 Company Overview
- 11.18.2 Company Revenue
- 11.18.3 Products
- 11.18.4 Recent Developments
11.19. Bio-Rad Laboratories Inc. (US)
- 11.19.1 Company Overview
- 11.19.2 Company Revenue
- 11.19.3 Products
- 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies